215 filings
Page 4 of 11
8-K
259au
11 Jun 21
Departure of Directors or Certain Officers
4:16pm
8-K
1tq3towfjc
29 Apr 21
Novocure Reports First Quarter 2021 Financial Results and Provides Company Update
6:08am
DEFA14A
brv5py85hh
27 Apr 21
Additional proxy soliciting materials
5:29pm
8-K
sbnymr9d
13 Apr 21
Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
9:17am
S-8
detfmu
25 Feb 21
Registration of securities for employees
4:05pm
8-K
kbjy7 ogb7nebggve7a5
25 Feb 21
Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update
6:30am
8-K
vbmgv2f dqu
8 Feb 21
Novocure Announces Addition to Its Board of Directors
4:33pm
8-K
2zkpnm3
1 Feb 21
Notice of Irrevocable Election
4:19pm
8-K
605 bqsozgdj
11 Jan 21
Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update
6:54am
8-K
tsgpu
9 Nov 20
Novocure Announces Closing of $150 Million Revolving Credit Facility with a Syndicate of Relationship Banks
7:49am
8-K
odslgmg 4696u2yza
5 Nov 20
Novocure Announces Closing of $575 Million 0% Convertible Senior Notes Private Placement
4:17pm
8-K
7j6rqr93gay gj
2 Nov 20
Novocure Announces Proposed Private Placement of $500 Million of Convertible Senior Notes
8:56pm
8-K
ef4th41p6bu25mk9nhff
29 Oct 20
Novocure Reports Third Quarter 2020 Financial Results and Provides Company Update
6:12am
UPLOAD
4qyui3
14 Oct 20
Letter from SEC
12:00am